Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8814)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 30, 2018 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mosly D, Turnbull A, Sims A, Ward C, Langdon S. Predictive markers of endocrine response in breast cancer. World Journal of Experimental Medicine 2018; 8(1): 1-7 [PMID: 30191138 DOI: 10.5493/wjem.v8.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315X/full/v8/i1/1.htm |
| Number | Citing Articles |
| 1 |
R. M. Parks, M. A. Albanghali, B. M. Syed, A. R. Green, I. O. Ellis, K-L. Cheung. Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray. Breast Cancer Research and Treatment 2021; 185(3): 647 doi: 10.1007/s10549-020-06023-4
|
| 2 |
Fatih Dal, Hasan Ökmen, Kıvılcım Ulusan, Semiha Battal Havare, Fadime Didem Can Trabulus, Şükrü Çolak, Ekrem Ferlengez, Serkan Sari. Prognostic Factors Effective on Survival in Unifocal Borderline Luminal B HER2-Negative and Triple-Negative Breast Cancers: a Cross-Sectional Study. Indian Journal of Surgery 2022; 84(6): 1231 doi: 10.1007/s12262-022-03294-7
|
| 3 |
Thais Pereira-Veiga, Mónica Martínez-Fernández, Carmen Abuin, Roberto Piñeiro, Victor Cebey, Juan Cueva, Patricia Palacios, Cristina Blanco, Laura Muinelo-Romay, Alicia Abalo, Clotilde Costa, Rafael López-López. CTCs Expression Profiling for Advanced Breast Cancer Monitoring. Cancers 2019; 11(12): 1941 doi: 10.3390/cancers11121941
|
| 4 |
A. Gouri, B. Benarba, A. Dekaken, H. Aoures, S. Benharkat. Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers. Current Drug Targets 2020; 21(10): 1008 doi: 10.2174/1389450121666200312105908
|
| 5 |
Luis Molina, Felipe Bustamante, Alexander Ortloff, Iraidi Ramos, Pamela Ehrenfeld, Carlos D. Figueroa. Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.563165
|
| 6 |
Cristian Scatena, Rosa Scarpitta, Lorenzo Innocenti, Mario Miccoli, Rachele Biancotti, Lucrezia Diodati, Matteo Ghilli, Antonio Giuseppe Naccarato. Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer. Breast Cancer Research and Treatment 2020; 182(1): 55 doi: 10.1007/s10549-020-05682-7
|
| 7 |
Cristina Ferreira Almeida, Georgina Correia-da-Silva, Natércia Teixeira, Cristina Amaral. Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies. Biochemical Pharmacology 2024; 223: 116178 doi: 10.1016/j.bcp.2024.116178
|
| 8 |
Ibrahem H. Kanbayti, William I. D. Rae, Mark F. McEntee, Meteb Al-Foheidi, Sawsan Ashour, Smeera A. Turson, Ernest U. Ekpo. Is mammographic density a marker of breast cancer phenotypes?. Cancer Causes & Control 2020; 31(8): 749 doi: 10.1007/s10552-020-01316-x
|
| 9 |
Tajda Tavčar Kunstič, Nataša Debeljak, Klementina Fon Tacer. Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors. Advances in Cancer Biology - Metastasis 2023; 7: 100086 doi: 10.1016/j.adcanc.2022.100086
|
| 10 |
Luka Dobovišek, Fran Krstanović, Simona Borštnar, Nataša Debeljak. Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment. Cancers 2020; 12(3): 525 doi: 10.3390/cancers12030525
|
| 11 |
Diego Barba, Ariana León-Sosa, Paulina Lugo, Daniela Suquillo, Fernando Torres, Frederic Surre, Lionel Trojman, Andrés Caicedo. Breast cancer, screening and diagnostic tools: All you need to know. Critical Reviews in Oncology/Hematology 2021; 157: 103174 doi: 10.1016/j.critrevonc.2020.103174
|
| 12 |
Richard S. Finn, Massimo Cristofanilli, Johannes Ettl, Karen A. Gelmon, Marco Colleoni, Carla Giorgetti, Eric Gauthier, Yuan Liu, Dongrui R. Lu, Zhe Zhang, Cynthia Huang Bartlett, Dennis J. Slamon, Nicholas C. Turner, Hope S. Rugo. Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials. Breast Cancer Research and Treatment 2020; 184(1): 23 doi: 10.1007/s10549-020-05782-4
|
| 13 |
Luka Dobovišek, Metka Novak, Fran Krstanović, Simona Borštnar, Tamara Lah Turnšek, Nataša Debeljak. Effect of combining CBD with standard breast cancer therapeutics. Advances in Cancer Biology - Metastasis 2022; 4: 100038 doi: 10.1016/j.adcanc.2022.100038
|
| 14 |
Arunkumar Arumugam, Ramadevi Subramani, Sushmita Bose Nandy, Daniel Terreros, Alok Kumar Dwivedi, Edward Saltzstein, Rajkumar Lakshmanaswamy. Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2. Experimental & Molecular Medicine 2019; 51(1): 1 doi: 10.1038/s12276-018-0197-8
|
| 15 |
Muhammad Farooq Khan, Fahd A. Nasr, Almohannad A. Baabbad, Ali S. Alqahtani, Mohammad A. M. Wadaan. Investigating the Anticancer Activity and Characterization of Bioactive Constituents of Moricandia sinaica (Boiss.) Boiss through In Vitro and In Silico Approaches in Triple-Negative Breast Cancer Cell Line. Applied Sciences 2021; 11(3): 1244 doi: 10.3390/app11031244
|
| 16 |
Muheng Liao, Jace Webster, Emily M. Coonrod, Katherine N. Weilbaecher, Christopher A. Maher, Nicole M. White. BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer. Clinical Breast Cancer 2024; doi: 10.1016/j.clbc.2024.02.007
|